Status:
WITHDRAWN
A Study to Evaluate Vaccines Against COVID-19 in the Real World
Lead Sponsor:
Humanity & Health Medical Group Limited
Conditions:
Chronic Liver Disease
Hepatic Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (COVID-19) have afflicted tens of millions of people in a worldwide pandemic. Consider...
Eligibility Criteria
Inclusion
- Subjects received COVID-19 vaccines;
- Able to comprehend and provide written informed consent in accordance with institutional guidelines.
Exclusion
- Not received any COVID-19 vaccines;
- Not willing to participate and/or give their written informed consent.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04775056
Start Date
August 1 2022
End Date
December 31 2023
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Humanity & Health Medical Group
Hong Kong, Hong Kong